Antibody titer threshold predicts anti-candidal vaccine efficacy even though the mechanism of protection is induction of cell-mediated immunity
about
Emerging drugs and vaccines for candidemiaAntifungal Th Immunity: Growing up in FamilyActive and passive immunization with rHyr1p-N protects mice against hematogenously disseminated candidiasisTh1-Th17 cells mediate protective adaptive immunity against Staphylococcus aureus and Candida albicans infection in mice.Horizontal transmission of Candida albicans and evidence of a vaccine response in mice colonized with the fungus.Prospects for development of a vaccine to prevent and control vaginal candidiasis.Vaccines for invasive fungal infectionsAntibodies to Pseudogymnoascus destructans are not sufficient for protection against white-nose syndrome.Vaccines in the treatment of invasive candidiasis.Recent progress in vaccines against fungal diseasesDendritic cells and vaccine design for sexually-transmitted diseases.The antifungal vaccine derived from the recombinant N terminus of Als3p protects mice against the bacterium Staphylococcus aureus.Vaccines to prevent systemic mycoses: holy grails meet translational realities.NDV-3 protects mice from vulvovaginal candidiasis through T- and B-cell immune response.Human fungal pathogen Candida albicans in the postgenomic era: an overview.Candida albicans Als3, a multifunctional adhesin and invasin.Immunotherapy of Fungal Infections.Immunological reactivity of blood from healthy humans to the rAls3p-N vaccine protein.The salivary gland as a target for enhancing immunization response.Ligation of Dectin-2 with a novel microbial ligand promotes adjuvant activity for vaccination.Immune responses induced by heat killed Saccharomyces cerevisiae: a vaccine against fungal infection.Host defense pathways against fungi: the basis for vaccines and immunotherapy.Antifungal Activity of Plasmacytoid Dendritic Cells and the Impact of Chronic HIV Infection.Methods of Controlling Invasive Fungal Infections Using CD8+ T Cells.Metals in fungal virulence.The Hyr1 protein from the fungus Candida albicans is a cross kingdom immunotherapeutic target for Acinetobacter bacterial infection.Human Anti-Als3p Antibodies Are Surrogate Markers of NDV-3A Vaccine Efficacy Against Recurrent Vulvovaginal Candidiasis.Mycoses and Antifungals: reviewing the basis of a current problem that still is a biotechnological target for marine products
P2860
Q26828993-872F4639-D961-4A28-87BA-92B2C3166F72Q27002920-B9EDF38C-987B-42DD-843B-C211694B8702Q28744094-ADF22F5A-5415-4CB2-A4AD-E97A4E1BF353Q33521257-C7168936-59BB-4D1C-BBD6-1153BA890514Q33983074-8C0C287D-92BE-48C3-BD03-E5863C3C7900Q34707478-9D3B65A0-220D-4B6B-879D-3D1EA587BCB0Q35161720-58658972-49F4-4A51-AB1D-6615CB0891D9Q35705655-F8ADB0D3-5DC6-42D1-B2C2-E724EBA2A819Q36147010-6AF390CE-C9A8-4D3E-84C6-937FDD127A90Q36179629-74EE2919-BBA7-4FAF-BA84-B7833B922D7FQ36681262-C552ED3E-07A2-4F3B-B4F8-1CE3E0692EF0Q36898452-FA03888D-24D0-4906-BFC1-AEA207175F88Q37390781-67173B25-1463-4306-9745-30D532277927Q37399422-CFBBCDFD-EEA6-4200-B828-633AB7B57550Q37557700-4F047107-DD8B-4A26-8E70-268BC62F88D1Q37813335-5F48B06D-C312-4636-BD89-B3A92929CBC0Q38635409-D5267A4F-91A6-4D4E-A9CC-DBD47C80A8F4Q39915594-798441B4-7DE9-427A-B181-1D449D2DF967Q40061301-C95399DC-9A80-4857-BBFC-893B1DEF2FD4Q40100084-D163C3D9-6238-488D-9707-349FFE76EA85Q41004226-A99FFF73-6A54-4436-A220-95BD6CB3F97FQ41901935-31E11EFF-D796-45A2-A565-0D3AFAD72D11Q47156382-2A80FF1D-D38B-485C-9751-ED8D829128BEQ47718243-03B60149-B3B0-4993-A1CC-E57D30750EBFQ50082780-20D99FC7-FA43-4D4D-8CF1-A307A810C2B6Q54215616-B71F1883-FEF6-456A-921E-DE31DB6C6318Q55396489-F5386790-D1DA-42F3-BA41-E5B04E149F01Q57900034-D4C270B4-F970-4A72-AE42-AFB907330623
P2860
Antibody titer threshold predicts anti-candidal vaccine efficacy even though the mechanism of protection is induction of cell-mediated immunity
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Antibody titer threshold predi ...... tion of cell-mediated immunity
@en
Antibody titer threshold predi ...... ion of cell-mediated immunity.
@nl
type
label
Antibody titer threshold predi ...... tion of cell-mediated immunity
@en
Antibody titer threshold predi ...... ion of cell-mediated immunity.
@nl
prefLabel
Antibody titer threshold predi ...... tion of cell-mediated immunity
@en
Antibody titer threshold predi ...... ion of cell-mediated immunity.
@nl
P2093
P2860
P356
P1476
Antibody titer threshold predi ...... tion of cell-mediated immunity
@en
P2093
Ashraf S Ibrahim
Brad Spellberg
Henry Otoo
John E Edwards
Peter Lipke
Tiffany Ho
Valentina Avanesian
P2860
P304
P356
10.1086/529204
P407
P577
2008-04-01T00:00:00Z